Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platform
Liping Yang(National Cancer Institute), Brad St. Croix(National Cancer Institute)
Cited by 4
Related Papers
Tumor stroma–targeted antibody-drug conjugate triggers localized anticancer drug release
|Journal of Clinical Investigation|2018|125
Cancer cell survival depends on collagen uptake into tumor-associated stroma
|Nature Communications|2022|61